Clickable polyoxetane carrier for drug delivery
A polymer is provided, comprising a subunit having the formula: wherein A, B, C, D, a, b, c, d, and p are defined herein. Compositions, methods of making, and methods of use are provided.
1. A polymer, comprising a subunit having the formula:
wherein:
A is independently hydrogen, C 1-10 alkyl, C 3-10 alkenyl, C 3-10 alkynyl, C 3-20 cycloalkyl, C 5-20 cycloalkenyl, C 5-25 aryl, —OR 1 , —COOR 1 , —C(O)R 1 , —C(O)-halogen, —SR 1 , —OSO 2 R 1 , —CONR 1 R 2 , —NR 1 R 2 , —N 3 , or halogen;
B is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
C is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
D is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
a is 1;
b is independently 0-10;
c is independently 1-20;
d is independently 0-20;
p is greater than 0;
R 1 and R 2 are independently hydrogen, C 1-10 alkyl, C 3-10 alkenyl, C 3-10 alkynyl, C 3-20 cycloalkyl, C 5-20 cycloalkenyl, or C 5-25 aryl;
and wherein one or more of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, alkylene, alkenylene, alkynylene, cycloalkylene, cycloalkenylene, and arylene may independently be branched, unbranched, unsubstituted, substituted, or contain at least one heteroatom.
2. The polymer of claim 1 , which has the formula:
wherein E is hydrogen or —C(O)CH═CH 2 .
3. The polymer of claim 1 , wherein A is —CH 3 , B is —CH 2 —, and C is —CH 2 —; a, b and c are 1; and d is 0.
4. The polymer of claim 2 , wherein E is hydrogen.
5. A polymer, comprising a subunit having the formula:
wherein:
A is independently hydrogen, C 1-10 alkyl, C 3-10 alkenyl, C 3-10 alkynyl, C 3-20 cycloalkyl, C 5-20 cycloalkenyl, C 5-25 aryl, —OR 1 , —COOR 1 , —C(O)R 1 , —C(O)-halogen, —SR 1 , —OSO 2 R 1 , —CONR 1 R 2 , —NR 1 R 2 , —N 3 , or halogen;
B is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
C is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
D is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
X is A, pharmaceutically active agent, physiological targeting agent, diagnostic agent, peptide, protein, nucleic acid, imaging agent, or combination of two or more of the foregoing;
a is 1;
b is independently 0-10;
c is independently 1-20;
d is independently 0-20;
q is greater than 0;
R 1 and R 2 are independently hydrogen, C 1-10 alkyl, C 3-10 alkenyl, C 3-10 alkynyl, C 3-20 cycloalkyl, C 5-20 cycloalkenyl, or C 5-25 aryl;
and wherein one or more of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, alkylene, alkenylene, alkynylene, cycloalkylene, cycloalkenylene, and arylene may independently be branched, unbranched, unsubstituted, substituted, or contain a hetero atom.
6. The polymer of claim 5 , which has the formula:
wherein E is hydrogen or —C(O)CH═CH 2 .
7. The polymer of claim 6 , wherein E is hydrogen.
8. The polymer of claim 5 , wherein the pharmaceutically active agent is docetaxel, gemcitabine, epirubicin, paclitaxel, geldanamycin, doxorubicin, camptothecin, topotecan, irinotecan, 9-aminocaptothecin, fluorouracil, platinate, cisplatin, carboplatin, DACH-Pt, anti-angiogenic drug, anti-fibrotic agent, CNS-active agent, therapeutic sensitizer, ATM kinase inhibitor, phosphatidylinositol 3-kinase/protein kinase, ATR kinase, DNA-PKcs kinase, cardio-vascular drug, immune-stimulating drug, antimicrobial agent, antiparasitic agent, anti-inflammatory agent, analgesic, anesthetic, or combination of two or more thereof.
9. The polymer of claim 5 , wherein the pharmaceutically active agent is camptothecin.
10. The polymer of claim 5 , wherein the subunit has one of the following formulas:
wherein p, q and r are greater than 0;
wherein p, q, r and x are greater than 0;
wherein p, q, r and x are greater than 0;
wherein p, q, r and x are greater than 0;
wherein p, q, r and x are greater than 0;
wherein o, p, q, and r are greater than 0;
or
wherein o, p, r and x are greater than 0.
11. The polymer of claim 5 , which has one of the following formulas:
wherein p, q and r are greater than 0;
wherein p, q, r and x are greater than 0;
wherein p, q, r and x are greater than 0;
wherein p, q, r and x are greater than 0;
wherein p, q, r and x are greater than 0;
wherein o, p, q, and r are greater than 0;
or
wherein o, p, r and x are greater than 0.
12. The polymer of claim 10 , wherein one or more of o, p, q, and r is independently 5-1000; and x is independently 1-100.
13. The polymer of claim 10 , wherein one or more of o, p, q, and r is independently 25-120; and x is independently 1-15.
14. The polymer of claim 11 , wherein one or more of o, p, q, and r is independently 5-1000; and x is independently 1-100.
15. The polymer of claim 11 , wherein one or more of o, p, q, and r is independently 25-120; and x is independently 1-15.
16. The polymer of claim 11 , wherein E is hydrogen.
17. A composition, comprising the polymer of claim 5 .
18. A polymer, comprising a subunit having the formula:
wherein:
C is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
D is independently C 1-10 alkylene, C 3-10 alkenylene, C 3-10 alkynylene, C 3-20 cycloalkylene, C 5-20 cycloalkenylene, C 5-25 arylene, —COO—, —C(O)—, —S—, —CONR 1 —, —NR 1 —, —CH 2 CH 2 O—, —O—, or combination of two or more of the foregoing;
c is independently 1-20;
d is independently 0-20;
p is greater than 0;
R 1 is independently hydrogen, C 1-10 alkyl, C 3-10 alkenyl, C 3-10 alkynyl, C 3-20 cycloalkyl, C 5-20 cycloalkenyl, or C 5-25 aryl;
and wherein one or more of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, alkylene, alkenylene, alkynylene, cycloalkylene, cycloalkenylene, and arylene may independently be branched, unbranched, unsubstituted, substituted, or contain a hetero atom.